» Articles » PMID: 31863337

Advancements in Cancer Stem Cell Isolation and Characterization

Overview
Publisher Springer
Specialty Cell Biology
Date 2019 Dec 22
PMID 31863337
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Occurrence of stem cells (CSCs) in cancer is well established in last two decades. These rare cells share several properties including presence of common surface markers, stem cell markers, chemo- and radio- resistance and are highly metastatic in nature; thus, considered as valuable prognostic and therapeutic targets in cancer. However, the studies related to CSCs pave number of issues due to rare cell population and difficulties in their isolation ascribed to common stem cell marker. Various techniques including flow cytometry, laser micro-dissection, fluorescent nanodiamonds and microfluidics are used for the isolation of these rare cells. In this review, we have included the advance strategies adopted for the isolation of CSCs using above mentioned techniques. Furthermore, CSCs are primarily found in the core of the solid tumors and their microenvironment plays an important role in maintenance, self-renewal, division and tumor development. Therefore, in vivo tracking and model development become obligatory for functional studies of CSCs. Fluorescence and bioluminescence tagging has been widely used for transplantation assay and lineage tracking experiments to improve our understanding towards CSCs behaviour in their niche. Techniques such as Magnetic resonance imaging (MRI) and Positron emission tomography (PET) have proved useful for tracking of endogenous CSCs which could be helpful in their identification in clinical settings.

Citing Articles

Nanodiamonds in biomedical research: Therapeutic applications and beyond.

Alexander E, Leong K PNAS Nexus. 2024; 3(5):pgae198.

PMID: 38983694 PMC: 11231952. DOI: 10.1093/pnasnexus/pgae198.


Cancer stem cells: advances in knowledge and implications for cancer therapy.

Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z Signal Transduct Target Ther. 2024; 9(1):170.

PMID: 38965243 PMC: 11224386. DOI: 10.1038/s41392-024-01851-y.


A study with cancer stem cells and three-dimensional tumoroids: investigation of the combined effects of 5-fluorouracil and doxorubicin in breast cancer.

Tayhan S Med Oncol. 2024; 41(7):185.

PMID: 38910198 PMC: 11194218. DOI: 10.1007/s12032-024-02423-4.


Revealing the pathogenesis of gastric intestinal metaplasia based on the mucosoid air-liquid interface.

Liu S, Wen H, Li F, Xue X, Sun X, Li F J Transl Med. 2024; 22(1):468.

PMID: 38760813 PMC: 11101349. DOI: 10.1186/s12967-024-05276-7.


Ginseng-derived compounds as potential anticancer agents targeting cancer stem cells.

Lee J, Lee H J Ginseng Res. 2024; 48(3):266-275.

PMID: 38707642 PMC: 11068999. DOI: 10.1016/j.jgr.2024.03.003.


References
1.
Pirozzi G, Tirino V, Camerlingo R, La Rocca A, Martucci N, Scognamiglio G . Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer. Oncol Rep. 2013; 29(5):1763-8. DOI: 10.3892/or.2013.2294. View

2.
Chen H, Wang Y, Wang T, Shi D, Sun Z, Xia C . Application prospective of nanoprobes with MRI and FI dual-modality imaging on breast cancer stem cells in tumor. J Nanobiotechnology. 2016; 14(1):52. PMC: 4918029. DOI: 10.1186/s12951-016-0195-8. View

3.
Sarioglu A, Aceto N, Kojic N, Donaldson M, Zeinali M, Hamza B . A microfluidic device for label-free, physical capture of circulating tumor cell clusters. Nat Methods. 2015; 12(7):685-91. PMC: 4490017. DOI: 10.1038/nmeth.3404. View

4.
N Almanaa T, Geusz M, Jamasbi R . A new method for identifying stem-like cells in esophageal cancer cell lines. J Cancer. 2013; 4(7):536-48. PMC: 3753528. DOI: 10.7150/jca.6477. View

5.
Alonso-Alconada L, Muinelo-Romay L, Madissoo K, Diaz-Lopez A, Krakstad C, Trovik J . Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. Mol Cancer. 2014; 13:223. PMC: 4190574. DOI: 10.1186/1476-4598-13-223. View